Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
ADAR1 affects HCV infection by modulating innate immune response.
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial.
Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.
Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.
High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs.
Recurrent coronary disease in HIV-infected patients: role of drug-drug interactions.
Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients.
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.
Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.